Connect with us
European Gaming Congress 2024

Uncategorized

Targeted Protein Degradation Market PROTAC Segment is Expected to Highest Growth Rate During 2024-2031 | Revealed by InsightAce Analytic Pvt. Ltd.

Published

on

targeted-protein-degradation-market-protac-segment-is-expected-to-highest-growth-rate-during-2024-2031-|-revealed-by-insightace-analytic-pvt-ltd.

 
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Targeted Protein Degradation Market“- Distribution by Type of Degrader (SERD, PROTAC and Molecular Glue), Target Indication (Breast Cancer and Multiple Myeloma), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031.”
The Targeted Protein Degradation Market is estimated to reach over USD 2.65 Bn by 2031, exhibiting a CAGR of 26.3% during the forecast period.
Targeted protein degradation (TPD) seeks to completely remove specific proteins from the cell, rather than merely inhibiting their activity. This approach can potentially provide more effective and sustained treatment outcomes for various diseases by thoroughly eliminating disease-causing proteins. By leveraging the cell’s natural degradation pathways, TPD can address issues that traditional therapies cannot, such as drug resistance and incomplete inhibition. Consequently, this innovative strategy holds significant promise for advancing the treatment of conditions like cancer, neurodegenerative diseases, and infectious diseases, offering new hope for patients with previously intractable conditions.
Targeted protein degradation (TPD) seeks to completely remove specific proteins from the cell, rather than merely inhibiting their activity. This approach can potentially provide more effective and sustained treatment outcomes for various diseases by thoroughly eliminating disease-causing proteins. By leveraging the cell’s natural degradation pathways, TPD can address issues that traditional therapies cannot, such as drug resistance and incomplete inhibition. Improved techniques in drug delivery, high-throughput screening, and protein engineering are enhancing the efficacy and specificity of TPD therapies.
Download Free Sample and ToC of the Report: https://www.insightaceanalytic.com/request-sample/2530
List of Prominent Players in the Targeted Protein Degradation Market:

Arvinas
Bristol-Myers Squibb
C4 Therapeutics
Loxo Oncology
Olema Oncology
Radius Health
AstraZeneca
Roche
BeiGene
InnoCare Pharma
Kangpu Biopharmaceuticals
Kintor Pharmaceuticals
Medivir
Monte Rosa Therapeutics
Ranok Therapeutics
Sanofi
Zentalis Pharmaceuticals
Eisai Therapeutics

Targeted Protein Degradation Market Report Scope:

Report Attribute

Specifications

Advertisement
Stake.com

Market Size Value In 2023

USD 0.42 Bn

Revenue Forecast In 2031

USD 2.65 Bn

Growth Rate CAGR

Advertisement
Stake.com

CAGR of 26.3% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Advertisement
Stake.com

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Advertisement
Stake.com

By Distribution by Type of Degrader, Target Indication

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia

Advertisement
Stake.com

Order 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2530
Market Dynamics:
Drivers:
The promising potential of TPD to transform disease treatment is attracting significant interest and investment from venture capitalists and pharmaceutical companies. Positive outcomes from ongoing research and clinical trials are boosting confidence in TPD therapies, accelerating their development. Additionally, partnerships between pharmaceutical companies, biotech firms, and academic institutions are fostering innovation and expanding the reach of TPD research and applications. The global increase in diseases such as cancer and neurodegenerative disorders is creating a demand for innovative therapies, making TPD a valuable approach.
Challenges:
Developing PROTACs and other TPD molecules is technically complex, requiring precise design to ensure efficacy and selectivity. Potential off-target effects and toxicity are significant concerns, necessitating thorough evaluation in preclinical and clinical trials. Additionally, high research and development costs, along with the need for extensive clinical trials, can be prohibitive for some companies.
Regional Trends:
There’s a growing focus on personalized medicine in North America, with an emphasis on developing targeted therapies for specific patient populations. TPD aligns well with this trend, offering the potential for more precise and effective treatments. The region boasts a well-established and well-funded pharmaceutical industry with a strong track record of innovation in drug discovery. These companies have the resources and expertise to invest heavily in TPD research and development, propelling the market forward.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2530
Recent Developments:

In April 2024, Arvinas, Inc., announced that it has signed a strategic license agreement with Novartis for the global development and commercialization of ARV-766, Arvinas’ second-generation PROTAC® androgen receptor (AR) degrader for patients with prostate cancer. is a clinical-stage biotechnology company developing a new class of drugs based on targeted protein degradation. An asset purchase agreement for the sale of Arvinas’ preclinical AR-V7 program to Novartis is also a part of the transaction.
In September 2023, Bristol Myers Squibb is hosting a Research and Development (R&D) Day in New York to discuss the company’s R&D capabilities and strategy and provide information about its strong pipeline that supports sustainable long-term growth. The company’s leadership team will also showcase its improved R&D framework and unique research platforms, which are anticipated to provide exceptional productivity that produces top-notch early-stage candidates and noticeably shortens R&D timelines.

Segmentation of Targeted Protein Degradation Market.
By Type of Degrader

SERD
PROTAC
Molecular Glue

By Target Indication

Advertisement
Stake.com

Breast Cancer
Multiple Myeloma

By Region
North America–

The US
Canada
Mexico

Europe–

Germany
The UK
France
Italy
Spain
Rest of Europe

Advertisement
Stake.com

Asia-Pacific–

China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific

Latin America–

Brazil
Argentina
Rest of Latin America

 Middle East & Africa–

Advertisement
Stake.com

GCC Countries
South Africa
Rest of the Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2530
Why should buy this report:

To receive a comprehensive analysis of the prospects for global Targeted Protein Degradation market
To receive industry overview and future trends of global Targeted Protein Degradation market
To analyze the Targeted Protein Degradation market drivers and challenges
To get information on the Targeted Protein Degradation market size value (US$ Mn) forecast till 2031
Major Investments, Mergers & Acquisition in global Targeted Protein Degradation industry

Other Related Reports Published by InsightAce Analytic:
SERD Therapeutics Market
Molecular Glue Degrader Market
Protein Design and Engineering Market
Check Our Satisfied Clients Portfolio @ https://www.insightaceanalytic.com/our-clients
The post Targeted Protein Degradation Market PROTAC Segment is Expected to Highest Growth Rate During 2024-2031 | Revealed by InsightAce Analytic Pvt. Ltd. appeared first on HIPTHER Alerts.

Advertisement
Stake.com
Continue Reading
Advertisement
Stake.com

Uncategorized

Darktrace recognized as the winner of 2024 Microsoft UK Partner of the Year

Published

on

darktrace-recognized-as-the-winner-of-2024-microsoft-uk-partner-of-the-year

 
Darktrace today announced it has won the UK 2024 Microsoft Partner of the Year Award.
The company was honored among a global field of top Microsoft partners for demonstrating excellence in innovation and implementation of customer solutions based on Microsoft technology.
“It is an amazing accolade to be recognized in this way by a company we admire and work with closely,” said Nicole Eagan, Darktrace Chief Strategy & AI Officer, “Microsoft and Darktrace are a powerful combination, delivering proactive cyber protection tailored to organizations by combining large scale threat intelligence with security insights unique to each customer’s digital footprint. Our ambition is to continuously extend and elevate the Microsoft security suite including email, Azure and Copilot.”
The Microsoft Partner of the Year Awards recognize Microsoft partners that have developed and delivered outstanding Microsoft Cloud applications, services, devices, and AI innovation during the past year.
Awards were classified in various categories, with honorees chosen from more than 4,700 nominations from more than 100 countries. Darktrace was recognized for providing outstanding solutions and services in the UK.
“Congratulations to the winners and finalists of the 2024 Microsoft Partner of the Year Awards!” said Nicole Dezen, Chief Partner Officer and Corporate Vice President at Microsoft. “The momentum generated by numerous AI & Copilot announcements this year fueled innovation from our partners, enabling groundbreaking services and solutions to customers. I am inspired by the capability and creativity in our partner ecosystem and this year’s winners beautifully demonstrate the best of what’s possible with AI and the Microsoft Cloud.”
The 2024 Microsoft Partner of the Year Awards are announced ahead of the MCAPS Start 2024 Microsoft Partner of the Year Awards digital event on July 10th and 11th. Partners will receive recognition at MCAPS Start for Partners ahead of in person celebrations during the week of Microsoft Ignite in November.
Additional details on the 2024 awards are available on the Microsoft Partner blog: https://aka.ms/POTYA2024_announcement. The complete list of categories, winners and finalists can be found at https://aka.ms/2024POTYAWinnersFinalists.
The post Darktrace recognized as the winner of 2024 Microsoft UK Partner of the Year appeared first on HIPTHER Alerts.

Continue Reading

Uncategorized

Chambers and Partners Research Yields Multiple Global Honors for J.S. Held and Experts

Published

on

chambers-and-partners-research-yields-multiple-global-honors-for-js.-held-and-experts

 
Global consulting firm J.S. Held, proudly celebrating 50 transformative years, announces the recognition of multiple experts and firmwide expertise in Chambers and Partners’ Annual Guides: Crisis & Risk Management and Litigation Support firms.
The J.S. Held Global Investigations team is once again recognized for expertise in Political Risk, Investigative Due Diligence, and Asset Tracing & Recovery. New for 2024, the Global Investigations team, in concert with the Environmental Health & Safety team, is recognized among the leading global Environmental, Social & Governance Risk experts. Further, the Global Investigations experts in the United Kingdom and the Asia Pacific are recognized in Business Intelligence & Investigations.
J.S. Held is proud to share the recognition of the team expertise and individual experts who received top Chambers and Partners rankings in the areas of:
Asset Tracing & Recovery – Global | Band 1
Peter Pender-Cudlip, Global Investigations & Intelligence Expert and Senior Managing Director within the J.S. Held Global Investigations practice. Peter advises clients on commercial and sovereign asset tracing, complex fraud investigations, and a wide range of cross-border litigation and arbitration matters.
“[Peter]… understands what is important for blue-chip clients and is able to get useful and usable information with his team. Peter is great to deal with, and he gets results.”
Ashley Messick, Global Asset Tracing & Recovery Expert and Senior Managing Director within the J.S. Held Global Investigations practice. Ashley leads J.S. Held’s Sovereign Debt Advisory and has extensive experience advising on sovereign and commercial disputes, asset recovery, and enforcement. She has led high-profile investigations involving debtors originating from Africa, Latin America, and Russia/Central Asia. She has tracked down assets and gathered intelligence in some of the world’s most difficult frontier markets, including West and Central Africa, the Middle East, and Russia.
“Ashley Messick has an amazing set of contacts, she’s results-oriented … extremely creative and subtle about looking for assets. She’s … thoughtful about developing strategies that fit with enforcement and … able to co-ordinate teams from across the globe.”
Political Risk – Global | Band 1
Livia Paggi, Political Risk, ESG, and Business Intelligence Expert and Managing Director within the J.S. Held Global Investigations practice. She advises multinational clients on doing business successfully in some of the world’s most challenging markets. Over the past decade, Livia has developed expertise in Russia and the wider Eurasia region.
“I worked with Livia and she is brilliant. She is dynamic and responsive.”
Philip Worman, Global Political Risk, Business Intelligence, and Investigations Expert and Senior Managing Director within the J.S. Held Global Investigations practice. Philip advises clients on doing business in emerging and frontier markets and has particular expertise in sanctions policy and risk mitigation.
“Philip Worman is outstanding in all respects; [he] has on-the-ground experience and has a real international coverage.”
Investigative Due Diligence – Global | Band 3
Chambers and Partners recognizes J.S. Held’s expertise in this category and observes, “J.S. Held provides clients with investigative due diligence alongside its extensive litigation support, asset tracing and recovery, and political risk practices. Its clients consist of sovereign entities, corporations, financial institutions, pension funds, private equity and hedge funds, legal firms, and high net worth individuals.”
Environmental, Social & Governance – Global | Band 3
Chambers, in recognizing J.S. Held’s expertise in this category, shares, “J.S. Held advises multinational companies on ESG issues around the world, using both its political risk expertise and its investigations and due diligence practice to assist with providing advice on ESG-related risks and disclosure obligations. J.S. Held recently acquired boutique consultancy Africa Matters, further strengthening its capabilities on ESG work in Africa.”
Business Intelligence & Investigations – Asia Pacific | Band 2
Bruno Vickers, Global Investigations & Business Intelligence Expert and Managing Director within the J.S. Held Global Investigations practice. Bruno has expertise in locating and recovering assets on cross-border disputes. He has acted for clients in many significant legal proceedings over the last decade, including those heard in local courts as well as in international arbitration centers such as London, Geneva, Dubai, Hong Kong, and Singapore.
“Bruno is very impressive … he runs a good outfit and clients really like him.”
Business Intelligence & Investigations – United Kingdom | Band 3
Sebastian Neave, Global Investigations & Business Intelligence Expert and Managing Director within the J.S. Held Global Investigations practice. Sebastian advises clients on complex disputes, cross-border litigation, and arbitration claims. Sebastian has developed specific expertise in disputes related to Russia and the CIS, working on high-profile matters emanating from the region. He has extensive experience gathering evidence to support recovery strategies against a diverse collection of states and state-owned commercial parties.
“Sebastian is outstanding… borders do not seem to exist for him.”
Equally important to the overall and individual expert rankings is the specific feedback from clients and peers acknowledging the work of J.S. Held:
“J.S. Held has an incredible ability to adapt their research and work product to the specifics of their respective clients across numerous industries.”
“These guys are top notch, without a doubt.”
“They have a very experienced team across various fields of expertise and jurisdictions.”
“The team is incredibly competent and responsive.”
“J.S. Held’s research, entrepreneurship, and responsiveness make them stand out.”
“Among other asset tracers, their work was by far the most comprehensive and specific.”
“…intelligence work is what they do, clients love them, and in the end, they find the gold.”
“They understand complex and sensitive matters and have the expertise to handle it efficiently.”
“J.S. Held [experts] are professional, responsive, and have an ability to get information which is unrivalled. They provide us with sometimes 24-hour support.”
“I would highly commend their capacity to tackle complex matters with finesse and expertise.”
Commenting on J.S. Held expert recognitions by Chambers and Partners, Greg Esslinger, Executive Vice President and Global Investigations Practice Lead, shares, “Global Investigations at J.S. Held is home to strategic innovators, integrated collaborators, and recognized thought leaders who have created the next-generation investigations practice together—a multidisciplinary team with global reach and strong cultural competence.” Esslinger adds, “The real added value of J.S. Held investigation work is the ability to use human sources to fill information gaps, corroborate data, and generate new leads. As a firm, we have a wealth of experience identifying and approaching specific sources with direct knowledge of a sovereign, company, or individual’s assets to develop actionable intelligence. ”
The global forensics team utilizes best-of-breed technology to support complex data challenges. Experts leverage multiple technology partners with a clear view to appropriate integration of GenAI and related tools. Application includes data collection, managing disparate data sources, translation of foreign language documents, and processing information from emerging off-channel communications and collaboration tools. The result: J.S. Held’s clients can focus on strategy and know that technology is on their side.
Learn more about the dedicated and entrepreneurial experts who help transform J.S. Held, explore our story, and celebrate this momentous milestone, our 50 & Forward celebration, with us at jsheld.com.
The post Chambers and Partners Research Yields Multiple Global Honors for J.S. Held and Experts appeared first on HIPTHER Alerts.

Continue Reading

Uncategorized

IBM study shows the Philippines lags in AI readiness in Southeast Asia

Published

on

ibm-study-shows-the-philippines-lags-in-ai-readiness-in-southeast-asia

 
A recent study commissioned by IBM has found that the Philippines is lagging behind its Southeast Asian counterparts in terms of artificial intelligence (AI) readiness. Conducted by Ecosystm, a digital research and advisory firm based in Singapore, the study surveyed 372 technology, data, and business leaders across five ASEAN countries.
The results from the IBM survey indicate differing levels of AI readiness within the region, with Singapore at the forefront—23% of respondents there consider their organizations ready to leverage AI. This is followed by Indonesia at 22%, Thailand at 20%, Malaysia at 19%, and the Philippines trailing at 16%.
Titled “The AI Readiness Barometer: ASEAN’s AI Landscape,” IBM’s report provides detailed insights into both the challenges and opportunities of AI adoption in the region. It outlines five stages of AI readiness: Traditional, Emerging, Consolidating, Transformative, and AI-first. Organizations in the Traditional stage exhibit limited AI capabilities, while those in the Emerging stage are starting to engage with AI technologies. The Consolidating stage sees AI being integrated into wider operational areas, and the Transformative stage marks the use of AI to drive significant organizational changes. The AI-first stage represents organizations where AI is central to both strategy and operations.
The emergence of Generative AI (GenAI), notably since the release of OpenAI’s ChatGPT in late 2022, has significantly impacted industries worldwide. Despite the initial enthusiasm, many organizations are still grappling with how to fully utilize AI to enhance business efficiency and increase revenue. The report stresses the importance of moving beyond the initial excitement to integrate AI into core decision-making processes, thereby unlocking its transformative potential.
The study points out several industries beginning to utilize AI effectively. In the manufacturing sector, which includes automotive and electronics, 18% of organizations are employing AI. This is followed by the financial services sector, including banking, at 17%, and government entities at 16%. The travel and transportation sector is at 9%, while consumer and retail, as well as telecom and media sectors, both stand at 8%.
However, despite the increased uptake of AI, the report underscores that governance and compliance, crucial for AI deployment, are not currently prioritized by many organizations. Only 13% of respondents are concentrating on improving data governance and compliance. More focus is being given to identifying business use cases for pilots or Proof of Concepts (PoCs) at 25%, enhancing data quality, interoperability, and consistency at 22%, upskilling and reskilling employees at 21%, and adopting new technologies for data management at 19%.
Source: backendnews.net
 
The post IBM study shows the Philippines lags in AI readiness in Southeast Asia appeared first on HIPTHER Alerts.

Continue Reading

Trending